Cardiac allograft vasculopathy (CAV) is a distinct form of coronary artery disease that
represents a major cause of death beyond the first year after heart transplantation. The …

Background Positron emission tomography (PET) has demonstrated utility for diagnostic and
prognostic assessment of cardiac allograft vasculopathy (CAV) but has not been evaluated …

Heart transplantation is the treatment of choice for patients with end-stage heart failure.
Recent advancements in surgical techniques and postoperative management, including …

Background Positron emission tomography (PET) myocardial flow reserve (MFR) is a
noninvasive method of detecting cardiac allograft vasculopathy in recipients of heart …

Background Cardiac allograft vasculopathy (CAV) limits long-term survival after heart
transplantation (HT). This study evaluates the relationship between clinically significant …

Aims The short-term risk of moderate–severe cardiac allograft vasculopathy (CAV) after a
low-risk positron emission tomography/computed tomography (PET/CT) is unknown, and …

Cardiac allograft vasculopathy (CAV) remains a major limitation for the long-term success of
orthotopic heart transplantation (OHT) and one of the leading causes of mortality beyond the …

INTRODUCTION Cardiac allograft vasculopathy is a fibroproliferative coronary pan-
arteriopathy that affects one in two heart transplant (HT) recipients and is a leading cause of …

State of the art of cardiac SPECT imaging continues to advance. Contemporary clinical
applications of cardiac SPECT are reviewed and illustrated. Beyond traditional stress and …

Myocardial blood flow (MBF) assessment in conjunction with PET perfusion imaging has
become commonplace in cardiac PET laboratories. The clinical value is well described and …